Mangoceuticals, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -9.21M-8.71M
Depreciation and Depletion 0.02M0.01M
Share-based Compensation 1.53M2.11M
Gains from Investment Securities 0.18M0.16M
Non-cash Items 0.12M0.14M
Cash from Operations -7.00M-4.86M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.02M0.01M
Change in Working Capital
Change in Inventory 0.02M
Change in Accured Expenses 0.11M0.70M
Change in Taxes 0.00M-0.01M
Other Working Capital Changes -0.06M-0.06M
Investing Activities
Capital Expenditures 0.00M
Sales of Property, Plant and Equipment 0.07M
Cash from Investing Activities -0.00M0.07M
Financing Activities
Cash from Financing Activities 7.06M4.13M
Dividend Payments
Dividends Paid - Common 0.80M
Additional items
Exchange Rate Effect -0.01M
Change in Cash 0.06M-0.67M
Beginning Cash Balance 0.68M0.73M
Free Cash Flow -7.00M-4.86M
Net Cash Flow 0.06M-0.67M